NOVO NORDISK A S (NVO)
Clinical trial NCT06752967 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-29 → 2026-06-25 3. primary completion date: 2026-06-29 → 2026-06-25 4. enrollment: 45 → 47 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical